Delivery Order SPE2DB22D9239-SPE2DB25FDM22
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,123.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Purixan 20 mg/ml oral suspension in 100ml quantities. This delivery order, issued on August 25, 2025, with an ultimate completion date of September 16, 2025, carries firm fixed-price terms and was not issued under any set-aside designation. The order falls under DMS Pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $16,331.04 order is for the supply of Purixan, a 20 mg/mL oral suspension medication, with a completion date of October 19, 2021. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA, valued at up to $499,999,999 and running through...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Purixan 20 mg/ml oral suspension in 100 ml quantities. This $6,371.04 firm fixed-price delivery order was awarded on August 7, 2025, with an ultimate completion date of August 28, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis leveraging...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,004.26 contract is for the supply of Purixan 20 mg/ml oral suspension in 100 ml bottles, with a period of performance through October 30, 2023. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which...
- The Defense Logistics Agency awarded a delivery order valued at $1,061.84 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Purixan 20 mg/ml oral suspension (100 ml). The contract is a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, and represents a continuation of DMS Pharmaceutical Group's substantial relationship with the federal government through pharmaceutical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,061.84, is for the delivery of Purixan 20 mg/ml oral suspension in 100 ml containers. The contract is a firm fixed-price delivery order with a period of performance through May 22, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $2,123.70 firm fixed-price delivery order is for the supply of PURIXAN 20 MG/ML oral suspension in 100 mL bottles, with a completion date of July 16, 2025. DMS Pharmaceutical Group holds a large Indefinite Delivery Contract (IDC) valued at $499,999,999 with the DLA under the SPE2DB program, which enables the agency to issue...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, is a delivery order valued at $10,228.60 for the supply of a pharmaceutical product, Purixan 20 mg/mL oral suspension. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,061.84 firm fixed-price delivery order is for the pharmaceutical product PURIXAN 20 MG/ML ORAL SUSP 100ML, with a completion date of June 11, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, valued at $2,045.74, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This order was issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA to provide a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. The...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDM22Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,123.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Purixan 20 mg/ml oral suspension in 100ml quantities. This delivery order, issued on September 24, 2025, with an ultimate completion date of October 16, 2025, represents a firm fixed-price contract with no set-aside designation applied. The award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, a $499.9 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products to support medical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group, registered in the System for Award Management since 2001, has established itself as a critical supplier within the federal pharmaceutical supply chain through its robust portfolio of delivery orders covering prescription medications, biologics, and medical consumables. The company's expertise in distributing both branded and generic pharmaceutical products to military and federal healthcare systems, combined with its woman-owned small business status, has enabled it to secure multiple contracts with the Defense Logistics Agency without competing under set-aside restrictions, demonstrating its competitive strength in federal procurement markets.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 9/24/25 |